Evidence map›Paper›PMID 30291340›Full record

ArticleEuropean journal of human genetics : EJHG2019

Heterozygous loss-of-function variants of MEIS2 cause a triad of palatal defects, congenital heart defects, and intellectual disability.

Rosalind Verheije, Gabriel S Kupchik, Bertrand Isidor, Hester Y Kroes, Sally Ann Lynch, Lara Hawkes, Maja Hempel, Bruce D Gelb, Jamal Ghoumid, Guylaine D'Amours and 35 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Functional analysis ofFrontiers in genetics · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Human Genetics of Ventricular Septal Defect.Advances in experimental medicine and biology · 2024
    Article
  14. Article
  15. Article
  16. Transcription factors in microcephaly.Frontiers in neuroscience · 2023
    Review
  17. The opportunities and challenges of usingFrontiers in physiology · 2023
    Article
  18. Article
  19. How "Neuronal" Are Human Skin Mast Cells?International journal of molecular sciences · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 20 institutions in 11 countries.

Rosalind VerheijeCenter for Human Genetics, Catholic University Leuven, Leuven, Belgium.
Gabriel S KupchikDivision of Medical Genetics, Infants and Children's Hospital of Brooklyn, Maimonides Medical Center, Brooklyn, NY, USA.
Bertrand IsidorCHU Nantes, Service de génétique médicale, Nantes, France.
Hester Y KroesDepartment of Medical Genetics, University Medical Center Utrecht, Utrecht, Netherlands.
Sally Ann LynchDepartments of Clinical Genetics, Children's University Hospital Temple Street, Dublin, Ireland.
Lara HawkesOxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Maja HempelInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bruce D GelbThe Mindich Child Health and Development Institute and the Departments of Pediatrics and Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID http://orcid.org/0000-0001-8527-5027
Jamal GhoumidService de Génétique Clinique, Hôpital Jeanne de Flandre, CHU Lille, Lille, France.ORCID http://orcid.org/0000-0002-7111-0050
Guylaine D'AmoursService de génétique médicale, CHU Sainte-Justine, Département de Pédiatrie, Université de Montréal, Montréal, QC, Canada.
Kate ChandlerManchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Christèle DubourgLaboratoire de Génétique Moléculaire, CHU Pontchaillou, Rennes, France.
Sara LoddoLaboratory of Medical Genetics, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
Zeynep TümerApplied Human Molecular Genetics, Kennedy Center, Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Glostrup, Denmark.
Charles Shaw-SmithInstitute of Biomedical & Clinical Science, University of Exeter Medical School, Exeter, UK.
Mathilde NizonCHU Nantes, Service de génétique médicale, Nantes, France.
Michael ShevellDepartment of Pediatrics, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
Evelien Van HoofCenter for Human Genetics, Catholic University Leuven, Leuven, Belgium.
Kwame Anyane-YeboaDivision of Clinical Genetics, Department of Pediatrics, Columbia University Medical Center, New York, NY, USA.
Gaetana CerboneDivision of Medical Genetics, "S.G. Moscati" Hospital, Avellino, Italy.
Jill Clayton-SmithManchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Benjamin CognéCHU Nantes, Service de génétique médicale, Nantes, France.
Pierre CorreService de Stomatologie, CHU Nantes, Nantes, France.
Anniek CorveleynCenter for Human Genetics, Catholic University Leuven, Leuven, Belgium.
Marie De BorreCenter for Human Genetics, Catholic University Leuven, Leuven, Belgium.
Tina Duelund HjortshøjApplied Human Molecular Genetics, Kennedy Center, Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Glostrup, Denmark.
Mélanie FradinService de Génétique Médicale, Centre de Reference Anomalies du Développement, CHU Rennes, Rennes, France.
Marc GewilligPediatric and Congenital Cardiology, UZ Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-4595-5922
Elizabeth GoldmuntzDivision of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Greet HensDepartment of Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium.
Emmanuelle LemyreService de génétique médicale, CHU Sainte-Justine, Département de Pédiatrie, Université de Montréal, Montréal, QC, Canada.
Hubert JournelService de Génétique Médicale, Centre de Reference Anomalies du Développement, CHU Rennes, Rennes, France.
Usha KiniOxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Fanny KortümInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Cedric Le CaignecCHU Nantes, Service de génétique médicale, Nantes, France.
Antonio NovelliLaboratory of Medical Genetics, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
Sylvie OdentService de Génétique Médicale, Centre de Reference Anomalies du Développement, CHU Rennes, Rennes, France.
Florence PetitService de Génétique Clinique, Hôpital Jeanne de Flandre, CHU Lille, Lille, France.
Anya Revah-PolitiInstitute for Genomic Medicine, Columbia University Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-3328-4252
Nicholas StongInstitute for Genomic Medicine, Columbia University Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-0678-637X
Tim M StromInstitute for Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Ellen van BinsbergenDepartment of Medical Genetics, University Medical Center Utrecht, Utrecht, Netherlands.
DDD study
Koenraad DevriendtCenter for Human Genetics, Catholic University Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-3651-2548
Jeroen BreckpotCenter for Human Genetics, Catholic University Leuven, Leuven, Belgium. Jeroen.Breckpot@uzleuven.be.
Columbia University Irving Medical Center · USManchester Academic Health Science Centre · GBCentre Hospitalier Universitaire Sainte-Justine · CACopenhagen University Hospital · DKInserm · FRUniversität Hamburg · DEBambino Gesù Children's Hospital · ITCentre Hospitalier Universitaire de Lille · FRCentre Hospitalier Universitaire de Nantes · FRChildren's Hospital of Philadelphia · USMaimonides Medical Center · USMunich University of Applied Sciences · DEUniversity Medical Center Utrecht · NLUniversity of Exeter · GBCenter for Human Genetics · USGénétique Médicale & Génomique Fonctionelle · FRMcGill University · CAOxford University Hospitals NHS Trust · GBTemple Street Children's University Hospital · IEUniversitair Ziekenhuis Leuven · BE

Funding

Administrative Coordinating Center: Cardiovascular Development and Pediatric Cardiac Genomics ConsortiaU01HL131003 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI CNOTA, JAMES, OLLBERDING, NICHOLAS J · 2016 to 2024
$54.8M
Genetics of Hypoplastic Left Heart SyndromeUM1HL128761 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI BERNSTEIN, DANIEL, SRIVASTAVA, DEEPAK · 2015 to 2019
$2.5M
The Genomic Basis of Congenital Heart Disease and Neurodevelopmental OutcomesUM1HL098147 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI NEWBURGER, JANE W., ROBERTS, AMY E · 2015 to 2019
$2.4M
Genetics of conotruncal defects and associated neurodevelopmental outcomesUM1HL098123 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GELB, BRUCE D · 2015 to 2019
$2.3M
Genetics and genomics of congenital heart disease and associated neurodevelopmental abnormalitiesUM1HL098162 · NHLBI · YALE UNIVERSITY · PI BRUECKNER, MARTINA, GUPTA, ABHA RANI · 2015 to 2019
$2.2M
Bridging the Gap between Genomics and Clinical Outcomes in CHDUM1HL128711 · NHLBI · UNIVERSITY OF UTAH · PI TRISTANI-FIROUZI, MARTIN, YANDELL, MARK DOUGLAS · 2015 to 2019
$2.0M
Transforming Genomics with 5 PB Big Omics Data Engine Cray CS300-AC SupercomputerS10OD018522 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2014 to 2014
$1.9M
Department of HealthNHLBI NIH HHS U01 HL131003NHLBI NIH HHS UM1 HL098123NHLBI NIH HHS UM1 HL098147NHLBI NIH HHS UM1 HL098162NHLBI NIH HHS UM1 HL128711NHLBI NIH HHS UM1 HL128761NIH HHS S10 OD018522Wellcome TrustWellcome Trust WT098051
6 · The paper itself

Abstract

Deletions on chromosome 15q14 are a known chromosomal cause of cleft palate, typically co-occurring with intellectual disability, facial dysmorphism, and congenital heart defects. The identification of patients with loss-of-function variants in MEIS2, a gene within this deletion, suggests that these features are attributed to haploinsufficiency of MEIS2. To further delineate the phenotypic spectrum of the MEIS2-related syndrome, we collected 23 previously unreported patients with either a de novo sequence variant in MEIS2 (9 patients), or a 15q14 microdeletion affecting MEIS2 (14 patients). All but one de novo MEIS2 variant were identified by whole-exome sequencing. One variant was found by targeted sequencing of MEIS2 in a girl with a clinical suspicion of this syndrome. In addition to the triad of palatal defects, heart defects, and developmental delay, heterozygous loss of MEIS2 results in recurrent facial features, including thin and arched eyebrows, short alae nasi, and thin vermillion. Genotype-phenotype comparison between patients with 15q14 deletions and patients with sequence variants or intragenic deletions within MEIS2, showed a higher prevalence of moderate-to-severe intellectual disability in the former group, advocating for an independent locus for psychomotor development neighboring MEIS2.

Indexed as

Loss of Function MutationAdolescentChildChild, PreschoolCleft PalateFemaleHeart Defects, CongenitalHeterozygoteHomeodomain ProteinsHumansIntellectual DisabilityMalePhenotypeSyndromeTranscription FactorsYoung AdultHomeodomain ProteinsMEIS2 protein, humanTranscription Factors

Identifiers

PMID30291340
PMCPMC6336847
OpenAlexW2894934289

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.